MAGLIO, ANGELANTONIO
MAGLIO, ANGELANTONIO
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
2023-01-01 Scioscia, G.; Tondo, P.; Nolasco, S.; Pelaia, C.; Carpagnano, G. E.; Caiaffa, M. F.; Valenti, G.; Maglio, A.; Papia, F.; Triggiani, M.; Crimi, N.; Pelaia, G.; Vatrella, A.; Foschino Barbaro, M. P.; Crimi, C.
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13
2022-01-01 Pelaia, Corrado; Pelaia, Giulia; Crimi, Claudia; Maglio, Angelantonio; Armentaro, Giuseppe; Calabrese, Cecilia; Sciacqua, Angela; Gallelli, Luca; Vatrella, Alessandro
Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral
2017-01-01 Vitale, C.; Conti, V.; Maglio, A.; Pelaia, G.; Molino, A.; Vatrella, A.
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study
2023-01-01 Pelaia, Corrado; Ferrante Bannera, Anna; Rotundo, Fioramante Lello; Tropea, Francesco Giuseppe; Armentaro, Giuseppe; Maglio, Angelantonio; Sciacqua, Angela; Vatrella, Alessandro; Pelaia, Girolamo
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?
2024-01-01 Pelaia, Corrado; Giacalone, Antonio; Ippolito, Gianluca; Pastore, Daniela; Maglio, Angelantonio; Piazzetta, Giovanna Lucia; Lobello, Nadia; Lombardo, Nicola; Vatrella, Alessandro; Pelaia, Girolamo
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report
2024-01-01 Maiorano, A.; Lupia, C.; Montenegro, N.; Neri, G.; Bruni, A.; Garofalo, E.; Longhini, F.; Crimi, C.; Maglio, A.; Vatrella, A.; Pelaia, G.; Pelaia, C.
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
2022-01-01 Pelaia, Corrado; Heffler, Enrico; Crimi, Claudia; Maglio, Angelantonio; Vatrella, Alessandro; Pelaia, Girolamo; Canonica, Giorgio Walter
Novel Biological Therapies for Severe Asthma Endotypes
2022-01-01 Pelaia, C.; Pelaia, G.; Crimi, C.; Maglio, A.; Stanziola, A. A.; Calabrese, C.; Terracciano, R.; Longhini, F.; Vatrella, A.
Novel Biological Therapies for Severe Asthma Endotypes
2022-01-01 Pelaia, C.; Pelaia, G.; Crimi, C.; Maglio, A.; Stanziola, A. A.; Calabrese, C.; Terracciano, R.; Longhini, F.; Vatrella, A.
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art
2020-01-01 Vatrella, A.; Maglio, A.; Pelaia, C.; Pelaia, G.; Vitale, C.
Phenotyping severe asthma: a rationale for biologic therapy
2020-01-01 Vatrella, A.; Maglio, A.; Pellegrino, S.; Pelaia, C.; Stellato, C.; Pelaia, G.; Vitale, C.
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
2021-01-01 Pelaia, C.; Procopio, G.; Deodato, M. R.; Florio, O.; Maglio, A.; Sciacqua, A.; Vatrella, A.; Pelaia, G.
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma
2021-01-01 Maglio, A.; Vitale, C.; Pellegrino, S.; Calabrese, C.; D'Amato, M.; Molino, A.; Pelaia, C.; Triggiani, M.; Pelaia, G.; Stellato, C.; Vatrella, A.
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
2023-01-01 Pelaia, C.; Benfante, A.; Busceti, M. T.; Caiaffa, M. F.; Campisi, R.; Carpagnano, G. E.; Crimi, N.; D'Amato, M.; Foschino Barbaro, M. P.; Maglio, A.; Minenna, E.; Nolasco, S.; Paglino, G.; Papia, F.; Pelaia, G.; Portacci, A.; Ricciardi, L.; Scichilone, N.; Scioscia, G.; Triggiani, M.; Valenti, G.; Vatrella, A.; Crimi, C.
Tezepelumab: A potential new biological therapy for severe refractory asthma
2021-01-01 Pelaia, C.; Pelaia, G.; Crimi, C.; Maglio, A.; Gallelli, L.; Terracciano, R.; Vatrella, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience | 1-gen-2023 | Scioscia, G.; Tondo, P.; Nolasco, S.; Pelaia, C.; Carpagnano, G. E.; Caiaffa, M. F.; Valenti, G.; Maglio, A.; Papia, F.; Triggiani, M.; Crimi, N.; Pelaia, G.; Vatrella, A.; Foschino Barbaro, M. P.; Crimi, C. | |
| Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 | 1-gen-2022 | Pelaia, Corrado; Pelaia, Giulia; Crimi, Claudia; Maglio, Angelantonio; Armentaro, Giuseppe; Calabrese, Cecilia; Sciacqua, Angela; Gallelli, Luca; Vatrella, Alessandro | |
| Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral | 1-gen-2017 | Vitale, C.; Conti, V.; Maglio, A.; Pelaia, G.; Molino, A.; Vatrella, A. | |
| Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study | 1-gen-2023 | Pelaia, Corrado; Ferrante Bannera, Anna; Rotundo, Fioramante Lello; Tropea, Francesco Giuseppe; Armentaro, Giuseppe; Maglio, Angelantonio; Sciacqua, Angela; Vatrella, Alessandro; Pelaia, Girolamo | |
| Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? | 1-gen-2024 | Pelaia, Corrado; Giacalone, Antonio; Ippolito, Gianluca; Pastore, Daniela; Maglio, Angelantonio; Piazzetta, Giovanna Lucia; Lobello, Nadia; Lombardo, Nicola; Vatrella, Alessandro; Pelaia, Girolamo | |
| Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report | 1-gen-2024 | Maiorano, A.; Lupia, C.; Montenegro, N.; Neri, G.; Bruni, A.; Garofalo, E.; Longhini, F.; Crimi, C.; Maglio, A.; Vatrella, A.; Pelaia, G.; Pelaia, C. | |
| Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets | 1-gen-2022 | Pelaia, Corrado; Heffler, Enrico; Crimi, Claudia; Maglio, Angelantonio; Vatrella, Alessandro; Pelaia, Girolamo; Canonica, Giorgio Walter | |
| Novel Biological Therapies for Severe Asthma Endotypes | 1-gen-2022 | Pelaia, C.; Pelaia, G.; Crimi, C.; Maglio, A.; Stanziola, A. A.; Calabrese, C.; Terracciano, R.; Longhini, F.; Vatrella, A. | |
| Novel Biological Therapies for Severe Asthma Endotypes | 1-gen-2022 | Pelaia, C.; Pelaia, G.; Crimi, C.; Maglio, A.; Stanziola, A. A.; Calabrese, C.; Terracciano, R.; Longhini, F.; Vatrella, A. | |
| Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art | 1-gen-2020 | Vatrella, A.; Maglio, A.; Pelaia, C.; Pelaia, G.; Vitale, C. | |
| Phenotyping severe asthma: a rationale for biologic therapy | 1-gen-2020 | Vatrella, A.; Maglio, A.; Pellegrino, S.; Pelaia, C.; Stellato, C.; Pelaia, G.; Vitale, C. | |
| Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease | 1-gen-2021 | Pelaia, C.; Procopio, G.; Deodato, M. R.; Florio, O.; Maglio, A.; Sciacqua, A.; Vatrella, A.; Pelaia, G. | |
| Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma | 1-gen-2021 | Maglio, A.; Vitale, C.; Pellegrino, S.; Calabrese, C.; D'Amato, M.; Molino, A.; Pelaia, C.; Triggiani, M.; Pelaia, G.; Stellato, C.; Vatrella, A. | |
| Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps | 1-gen-2023 | Pelaia, C.; Benfante, A.; Busceti, M. T.; Caiaffa, M. F.; Campisi, R.; Carpagnano, G. E.; Crimi, N.; D'Amato, M.; Foschino Barbaro, M. P.; Maglio, A.; Minenna, E.; Nolasco, S.; Paglino, G.; Papia, F.; Pelaia, G.; Portacci, A.; Ricciardi, L.; Scichilone, N.; Scioscia, G.; Triggiani, M.; Valenti, G.; Vatrella, A.; Crimi, C. | |
| Tezepelumab: A potential new biological therapy for severe refractory asthma | 1-gen-2021 | Pelaia, C.; Pelaia, G.; Crimi, C.; Maglio, A.; Gallelli, L.; Terracciano, R.; Vatrella, A. |